T. Buhr

1.1k total citations
37 papers, 839 citations indexed

About

T. Buhr is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, T. Buhr has authored 37 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 22 papers in Hematology and 16 papers in Rheumatology. Recurrent topics in T. Buhr's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Eosinophilic Disorders and Syndromes (14 papers) and Chronic Myeloid Leukemia Treatments (13 papers). T. Buhr is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Eosinophilic Disorders and Syndromes (14 papers) and Chronic Myeloid Leukemia Treatments (13 papers). T. Buhr collaborates with scholars based in Germany, Switzerland and Austria. T. Buhr's co-authors include A. Georgii, H. Choritz, Hans Kreipe, Guntram Büsche, V. Kaloutsi, Andreas Kreft, Guntram Buesche, Florian Länger, Kais Hussein and Oliver Bock and has published in prestigious journals such as American Journal Of Pathology, British Journal of Haematology and Leukemia.

In The Last Decade

T. Buhr

35 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Buhr Germany 17 664 561 331 260 66 37 839
Ellis J. Van Slyck United States 13 211 0.3× 284 0.5× 90 0.3× 83 0.3× 31 0.5× 29 528
Nicolas Duployez France 17 303 0.5× 621 1.1× 375 1.1× 135 0.5× 13 0.2× 67 950
RW McKenna United States 10 211 0.3× 533 1.0× 160 0.5× 38 0.1× 63 1.0× 14 798
W. Gaßmann Germany 16 199 0.3× 930 1.7× 302 0.9× 32 0.1× 74 1.1× 42 1.1k
Nathalie Boiret France 12 324 0.5× 246 0.4× 161 0.5× 84 0.3× 6 0.1× 18 492
C. Fabères France 15 296 0.4× 625 1.1× 95 0.3× 170 0.7× 13 0.2× 30 709
Caterina Micò Italy 11 292 0.4× 303 0.5× 190 0.6× 84 0.3× 5 0.1× 19 615
Toru Sakura Japan 19 162 0.2× 751 1.3× 178 0.5× 20 0.1× 29 0.4× 70 960
RS Negrin United States 10 123 0.2× 515 0.9× 126 0.4× 31 0.1× 74 1.1× 13 624
Eaves Ac Canada 11 207 0.3× 413 0.7× 80 0.2× 51 0.2× 17 0.3× 18 513

Countries citing papers authored by T. Buhr

Since Specialization
Citations

This map shows the geographic impact of T. Buhr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Buhr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Buhr more than expected).

Fields of papers citing papers by T. Buhr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Buhr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Buhr. The network helps show where T. Buhr may publish in the future.

Co-authorship network of co-authors of T. Buhr

This figure shows the co-authorship network connecting the top 25 collaborators of T. Buhr. A scholar is included among the top collaborators of T. Buhr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Buhr. T. Buhr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hussein, Kais, Oliver Bock, Katharina Theophile, et al.. (2009). JAK2V617F allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis. Experimental Hematology. 37(10). 1186–1193.e7. 52 indexed citations
3.
Buhr, T., et al.. (2008). Osteoporotische Wirbelkörperfrakturen bei systemischer Mastozytose ohne Hautbeteiligung. DMW - Deutsche Medizinische Wochenschrift. 117(45). 1717–1722.
4.
Hussein, Kais, Kai Brakensiek, Guntram Buesche, et al.. (2007). Different involvement of the megakaryocytic lineage by the JAK2V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis. Annals of Hematology. 86(4). 245–253. 16 indexed citations
5.
6.
Arkenau, Hendrik‐Tobias, et al.. (2005). Microangiopathic Hemolytic Anemia (MAHA) as Paraneoplastic Syndrome in Metastasized Signet Ring Cell Carcinomas: Case Reports and Review of the Literature. Zeitschrift für Gastroenterologie. 43(8). 719–722. 20 indexed citations
7.
8.
9.
Büsche, Guntram, H. Choritz, Florian Länger, Hans Kreipe, & T. Buhr. (2003). Evolution of Myelofibrosis in Chronic Idiopathic Myelofibrosis as Evidenced in Sequential Bone Marrow Biopsy Specimens. American Journal of Clinical Pathology. 119(1). 152–158. 57 indexed citations
10.
Rudolph, K. Lenhard, et al.. (2002). Telomerase Activity, Telomere Length, and Apoptosis: A Comparison between Acquired Cholesteatoma and Squamous Cell Carcinoma. Otology & Neurotology. 23(5). 793–798. 9 indexed citations
11.
Kreft, Andreas, et al.. (2000). Polycythaemia vera: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan. European Journal Of Haematology. 64(1). 32–41. 15 indexed citations
12.
Georgii, A., T. Buhr, Guntram Buesche, Andreas Kreft, & H. Choritz. (1996). Classification and Staging of Ph-negative Myeloproliferative Disorders by Histopathology from Bone Marrow Biopsies. Leukemia & lymphoma. 22(sup1). 15–29. 84 indexed citations
13.
Buhr, T. & A. Georgii. (1995). Das histologische Bild der An�mien in Knochenmarksbiopsien. Der Pathologe. 16(1). 46–52. 1 indexed citations
14.
Winkler, M., B Ringe, U. Jost, et al.. (1993). Conversion from cyclosporin to FK 506 after liver transplantation. Transplant International. 6(6). 319–324. 14 indexed citations
15.
Werner, Martin, et al.. (1993). Evidence from molecular genetic and cytogenetic analyses that bone marrow histopathology is reliable in the diagnosis of chronic myeloproliferative disorders. Virchows Archiv B Cell Pathology Including Molecular Pathology. 63(1). 199–204. 3 indexed citations
16.
Buhr, T., A. Georgii, & H. Choritz. (1993). Myelofibrosis in Chronic Myeloproliferative Disorders. Pathology - Research and Practice. 189(2). 121–132. 66 indexed citations
17.
Buhr, T., H. Choritz, & A. Georgii. (1992). The impact of megakaryocyte proliferation for the evolution of myelofibrosis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 420(6). 473–478. 33 indexed citations
18.
Kaloutsi, V., et al.. (1991). Megakaryocytes in chronic myeloproliferative disorders: Numerical density correlated between different entities. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 418(6). 493–497. 18 indexed citations
19.
Werner, Martin, et al.. (1991). Cytogenetics of chronic myelogenous leukemia (CML) correlated to the histopathology of bone marrow biopsies. Annals of Hematology. 63(4). 201–205. 19 indexed citations
20.
Georgii, A., K. F. Vykoupil, & T. Buhr. (1988). Preleukemia: Bone Marrow Histopathology in Myelodysplasia and Preleukemic Syndrome. Recent results in cancer research. 106. 159–171. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellis J. Van Slyck Breakdown of academic impact, for papers by Nicolas Duployez Breakdown of academic impact, for papers by RW McKenna Breakdown of academic impact, for papers by W. Gaßmann Breakdown of academic impact, for papers by Nathalie Boiret Breakdown of academic impact, for papers by C. Fabères Breakdown of academic impact, for papers by Caterina Micò Breakdown of academic impact, for papers by Toru Sakura Breakdown of academic impact, for papers by RS Negrin Breakdown of academic impact, for papers by Eaves Ac
Rankless by CCL
2026